Yu Wang

Yu Wang

Director Técnico/Científico/I+D en GENFLEET THERAPEUTICS (SHANGHAI) INC. .
Health Technology
Consumer Services

Perfil

Yu Wang is currently the Chief Medical Officer at Genfleet Therapeutics (Shanghai), Inc. and Abbisko Therapeutics Co., Ltd. He previously worked as the Director-Associate Medical at Eli Lilly Asia, Inc. from 2007 to 2010, Director-Medical at GlaxoSmithKline (China) Investment Co., Ltd. from 2010 to 2012, Director-Clinical Research at Sanofi (China) Investment Co. Ltd. from 2012 to 2013, Senior Research Member at Shanghai Sunway Biotech Co., Ltd. from 2005 to 2007, Partner at Zenrhyme Consulting Services Co. Ltd. from 2018 to 2020, and Chief Scientist Officer at Beijing Panacro Pharmaceutical Technology Co. Ltd. from 2016 to 2017.
Dr. Wang obtained a doctorate degree from Shanghai Medical College of Fudan University in 2000 and an undergraduate degree from Tongji Medical College of Huazhong University of Sci & Tech in 1995.

Cargos activos de Yu Wang

EmpresasCargoInicio
GENFLEET THERAPEUTICS (SHANGHAI) INC. Director Técnico/Científico/I+D 01/11/2020
Director Técnico/Científico/I+D 01/03/2020

Antiguos cargos conocidos de Yu Wang.

EmpresasCargoFin
Corporate Officer/Principal 01/09/2013
Director Técnico/Científico/I+D 01/03/2012
Eli Lilly Asia, Inc.
Director Técnico/Científico/I+D 01/02/2010
Ver el detalle de la experiencia de Yu Wang.

Formación de Yu Wang.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

43

Relaciones de 1er grado

8

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas8

Health Technology

Consumer Services

Eli Lilly Asia, Inc.

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology